NEOG.NASDAQNeogen CORP

Form 4: Neogen Corp CFO David H. Naemura Reports Stock and Option Transactions

Sentiment:

SEC Form 4 Filing


Neogen Corp's CFO, David H. Naemura, acquired 10,034 shares of common stock and 45,150 stock options on January 16, 2025.

Summary

  • David H. Naemura, the CFO of Neogen Corp, reported a transaction involving the company's stock on January 16, 2025.
  • He acquired 10,034 shares of common stock at a price of $11.6 per share.
  • Additionally, he acquired 45,150 stock options with an exercise price of $11.6 per share, exercisable starting January 16, 2025, and expiring on January 16, 2032.
  • The options and restricted stock units (RSUs) vest in equal annual installments over three years from the grant date.
  • Following these transactions, Mr. Naemura directly owns 71,468 shares of common stock and 45,150 stock options.

Sentiment

Score: 6

Explanation: The document is a routine SEC filing detailing insider transactions. It is neither particularly positive nor negative, but rather a standard disclosure.

Positives

  • The acquisition of shares and options by the CFO could be seen as a positive sign of confidence in the company's future performance.

Industry Context

This is a standard SEC Form 4 filing, which is common for corporate insiders reporting transactions in their company's stock. It is a routine part of corporate governance and transparency.

Comparison to Industry Standards

  • Form 4 filings are a standard practice for publicly traded companies in the United States, ensuring transparency of insider transactions.
  • The reported transactions are typical for executive compensation packages, which often include stock options and restricted stock units.

Stakeholder Impact

  • The transactions may have a minor positive impact on shareholder sentiment, as insider purchases can be seen as a sign of confidence.

Key Dates

DateDescription
01/16/2025Date of the stock and option transactions.
01/16/2032Expiration date of the stock options.
01/21/2025Date the form was signed by Christopher Sefcheck, Attorney in Fact.

Keywords

Neogen Corp, NEOG, insider trading, stock options, stock acquisition, Form 4, David H. Naemura, CFO, equity securities

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.